Skip to main content
Skip to main content
USPH logo

U.S. Physical Therapy, Inc. (USPH)

$72.67 +$0.32 (+0.44%) |Fair · 60
Bottom line: BUY — our Council read (60/100) and AI Score (60/100) broadly agree.
MCap: $1.11B| P/E Ratio: 815.5| Vol: 211.3K| Target: $102.00 (+40.4%)|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

U.S. Physical Therapy, Inc. (USPH) trades at $72.67 with AI Score 60/100 (Grade B+). U. S. Physical Therapy, Inc. Market cap: $1.11B, Sector: Healthcare.

Price live · AI analysis from May 7, 2026
U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics and provides industrial injury prevention services. The company focuses on pre- and post-operative care, sports-related injuries, and rehabilitation, operating across 39 states.

USPH stock analysis for 2026: Analysts have set a consensus price target of $102.00 for U.S. Physical Therapy, Inc., suggesting 40.4% upside from the current price of $72.67. The AI MoonshotScore is 60/100, indicating a bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 60/100 · B+

USPH: 1/1 perspectives are bullish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

U.S. Physical Therapy, Inc. (USPH) Healthcare & Pipeline Overview

CEOChristopher J. Reading
Employees4034
HeadquartersHouston, TX, US
IPO Year1992

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics, offering pre- and post-operative care, sports injury treatments, and industrial injury prevention. With a network of clinics across 39 states, the company addresses orthopedic and neurological rehabilitation needs, positioning itself in the fragmented healthcare services market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 7, 2026

What Is the Investment Thesis for USPH?

U.S. Physical Therapy, Inc. presents a compelling investment case based on its established market presence and growth potential within the expanding outpatient physical therapy sector. The company's decentralized operating model and focus on partnering with local therapists drive strong clinic performance and community engagement. With a market capitalization of $1.11B and a dividend yield of 2.46%, USPH offers a blend of growth and income potential. Key catalysts include the aging population and increasing demand for rehabilitation services, as well as strategic acquisitions to expand its clinic network. However, investors should be aware of risks such as reimbursement rate pressures and competition from other physical therapy providers. The company's P/E ratio of 815.5 and profit margin of 1.5% warrant careful consideration of valuation and profitability metrics.

Based on FMP financials and quantitative analysis

USPH Key Highlights

  • Market Cap of $1.11B reflects its position as a key player in the outpatient physical therapy market.
  • P/E ratio of 815.5 indicates a premium valuation, suggesting investor expectations of future growth.
  • Dividend Yield of 2.46% provides an income component to the investment, attractive to income-seeking investors.
  • Gross Margin of 22.0% shows the profitability of its core services, though there is room for improvement compared to industry leaders.
  • Operation of 591 clinics in 39 states demonstrates a wide geographic reach and established presence in the physical therapy market.

Who Are USPH's Competitors?

USPH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ATI ATI Inc. $191.02 +1.55% $26.07B 76
OMCL Omnicell, Inc. $45.96 +6.82% $2.09B 82
NHC National HealthCare Corporation $217.43 -0.46% $3.40B 98
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
TOI The Oncology Institute, Inc. $5.45 +3.22% $544.91M 61
ASTH Astrana Health, Inc. $47.56 -3.27% $2.36B 60

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are USPH's Key Strengths?

  • Established network of 591 clinics in 39 states.
  • Diversified service offerings including physical therapy and industrial injury prevention.
  • Decentralized operating model with strong local partnerships.
  • Experienced management team with a proven track record.

What Are USPH's Weaknesses?

  • Relatively low profit margin of 1.5%.
  • High P/E ratio of 815.5 may indicate overvaluation.
  • Dependence on reimbursement rates from insurance providers.
  • Exposure to regulatory changes in the healthcare industry.

What Could Drive USPH Stock Higher?

  • Continued expansion through strategic acquisitions of physical therapy practices.
  • Increasing demand for outpatient physical therapy services due to an aging population.
  • Growth in industrial injury prevention services as companies focus on employee well-being.
  • Potential for increased reimbursement rates from insurance providers.
  • Expansion of telehealth services to reach a wider patient base by Q4 2026.

What Are the Key Risks for USPH?

  • Rich valuation — a P/E of 815.5 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
  • Competition from other physical therapy providers in a fragmented market.
  • Changes in reimbursement policies and rates affecting revenue.
  • Economic downturn impacting patient demand for elective physical therapy services.
  • Rising operating costs, including labor and rent.
  • Regulatory changes in the healthcare industry impacting operations.

What Are the Growth Opportunities for USPH?

  • Expansion through Acquisitions: USPH can pursue strategic acquisitions of smaller physical therapy practices to expand its geographic footprint and market share. The fragmented nature of the industry provides ample opportunities for consolidation. By acquiring well-established practices, USPH can quickly integrate them into its network and leverage its operational expertise to improve profitability. This strategy allows for rapid growth and increased market presence in key regions. The outpatient rehabilitation market is projected to reach $37.8 billion by 2028, offering significant growth potential through acquisitions.
  • Telehealth Integration: Implementing telehealth services can expand USPH's reach and improve patient access, particularly in rural areas or for patients with mobility issues. Telehealth can also enhance patient engagement and adherence to treatment plans. By offering virtual consultations and remote monitoring, USPH can attract new patients and improve outcomes. The telehealth market is expected to grow significantly, driven by technological advancements and changing patient preferences. The global telehealth market is projected to reach $55.6 billion by 2027, presenting a substantial opportunity for USPH to capitalize on this trend.
  • Industrial Injury Prevention Services: Expanding its industrial injury prevention services can drive revenue growth and diversify USPH's revenue streams. By providing onsite injury prevention and rehabilitation services to Fortune 500 companies and other clients, USPH can tap into a large and growing market. These services help companies reduce workers' compensation costs and improve employee productivity. The market for workplace health and safety services is expected to grow as companies increasingly focus on employee well-being. The occupational health and safety market is projected to reach $7.8 billion by 2025, offering a significant growth opportunity for USPH.
  • Specialization in Specific Therapies: Developing specialized programs for specific conditions, such as sports-related injuries or neurological disorders, can attract new patients and differentiate USPH from competitors. By focusing on niche markets, USPH can establish itself as a leader in these areas and attract referrals from physicians and other healthcare providers. This strategy allows for higher reimbursement rates and improved patient outcomes. The market for specialized physical therapy services is expected to grow as the population ages and the prevalence of chronic conditions increases. The sports medicine market is projected to reach $9.7 billion by 2026, presenting a targeted growth opportunity for USPH.
  • Partnerships with Healthcare Providers: Forming strategic partnerships with hospitals, physician groups, and other healthcare providers can drive patient referrals and expand USPH's network. By collaborating with other healthcare providers, USPH can offer a comprehensive range of services to patients and improve care coordination. These partnerships can also lead to increased brand awareness and market share. The healthcare industry is increasingly focused on collaboration and integration, creating opportunities for USPH to partner with other providers. The integrated healthcare market is projected to reach $2.1 trillion by 2028, highlighting the potential benefits of strategic partnerships for USPH.

What Opportunities Does USPH Have?

  • Expansion through acquisitions of smaller physical therapy practices.
  • Growth in telehealth services to reach a wider patient base.
  • Increased demand for industrial injury prevention services.
  • Partnerships with hospitals and physician groups to drive referrals.

What Threats Does USPH Face?

  • Competition from other physical therapy providers.
  • Changes in reimbursement policies and rates.
  • Economic downturn affecting patient demand for services.
  • Rising operating costs and labor shortages.

What Are USPH's Competitive Advantages?

  • Established network of clinics across 39 states provides a wide geographic reach.
  • Decentralized operating model fosters strong local connections and patient relationships.
  • Focus on high-quality patient care and outcomes drives patient referrals and loyalty.
  • Industrial injury prevention services provide a diversified revenue stream.
  • Partnerships with local physical therapists create a strong competitive advantage.

What Does USPH Do?

Founded in 1990 and headquartered in Houston, Texas, U.S. Physical Therapy, Inc. (USPH) has grown into a significant operator of outpatient physical therapy clinics. The company provides a range of services, including pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. USPH operates through two segments: Physical Therapy Operations and Industrial Injury Prevention Services. The Physical Therapy Operations segment focuses on providing direct patient care through its network of clinics. The Industrial Injury Prevention Services segment offers onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. These services are delivered by physical therapists and specialized certified athletic trainers to Fortune 500 companies, insurers, and their contractors. As of December 31, 2021, USPH operated 591 clinics in 39 states and managed 35 physical therapy practice facilities. The company's business model emphasizes a decentralized approach, partnering with local physical therapists to manage and operate its clinics, fostering a strong connection with the communities they serve. This strategy allows USPH to maintain a high level of patient care and adapt to local market needs. The company continues to expand its footprint through acquisitions and the establishment of new clinics, solidifying its position in the competitive outpatient physical therapy market.

What Products and Services Does USPH Offer?

  • Operates outpatient physical therapy clinics across 39 states.
  • Provides pre- and post-operative care for orthopedic-related disorders.
  • Offers treatment for sports-related injuries.
  • Provides preventative care and rehabilitation for injured workers.
  • Offers neurological-related injury rehabilitation.
  • Provides industrial injury prevention services to Fortune 500 companies.
  • Manages physical therapy practice facilities.

How Does USPH Make Money?

  • Generates revenue through direct patient care at outpatient physical therapy clinics.
  • Earns revenue from industrial injury prevention services provided to companies.
  • Utilizes a decentralized operating model, partnering with local physical therapists.
  • Expands through acquisitions of existing physical therapy practices.

What Industry Does USPH Operate In?

U.S. Physical Therapy, Inc. operates within the growing outpatient physical therapy market, driven by an aging population, increasing prevalence of chronic conditions, and rising demand for sports-related injury rehabilitation. The industry is characterized by a fragmented competitive landscape, including large national chains, regional players, and independent clinics. USPH differentiates itself through its decentralized operating model and partnership approach with local therapists. The market is expected to continue its growth trajectory, fueled by technological advancements, telehealth integration, and evolving reimbursement models.

Who Are USPH's Key Customers?

  • Individuals seeking outpatient physical therapy services.
  • Patients requiring pre- and post-operative care.
  • Athletes and individuals with sports-related injuries.
  • Workers requiring rehabilitation services.
  • Fortune 500 companies seeking industrial injury prevention services.
AI Confidence: 73% Updated: May 7, 2026

USPH Valuation & Market Position

With a $1.11B market cap, U.S. Physical Therapy, Inc. sits in the small-cap segment of the market. Relative to its peer group, USPH's quantitative score of 60/100 is below the peer average of 77/100.

FY2026 estForward Outlook

Wall Street analysts project U.S. Physical Therapy, Inc. revenue of about $838.7M for fiscal 2026, with EPS near $2.80. The estimate reflects 6 contributing analysts.

F-Score 5/9Financial Health

U.S. Physical Therapy, Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 2.51 places it in the grey zone, a middle ground that warrants monitoring.

ROE 0%Key Financial Metrics

Return on equity for U.S. Physical Therapy, Inc. stands at 0.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.1%, showing how much profit it generates from its asset base. USPH trades at a trailing price-to-earnings ratio of 815.55, above the Healthcare sector average of ~23x. Its free cash flow yield is 6.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.19 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.1%, the inverse of the P/E and a quick read on earnings relative to price.

USPH Financials

Fundamental Snapshot

Revenue Growth (FY)
+16.3%
Net Income Growth (FY)
-43.1%
EPS Growth (FY)
-22.8%
Free Cash Flow Growth (FY)
-7.2%
Return on Equity (TTM)
+0.2%
Current Ratio
1.2
EV/EBITDA (TTM)
13.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests those in the know see value, signaling potential upside.
  • The community seems to be buzzing about USPH's consistent growth and expansion into new markets.
  • Positive sentiment around USPH's role in an aging population needing physical therapy services.
  • Market perception is favorable due to the company's stable business model and recurring revenue streams.

Bear Case

  • Some insiders have recently sold off shares, which could indicate concerns about future performance.
  • Community discussions highlight worries about increasing competition in the physical therapy sector.
  • There's a growing concern within the community regarding potential regulatory changes impacting reimbursement rates.
  • Market perception reflects some uncertainty about USPH's ability to maintain its growth rate in a changing healthcare landscape.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026

USPH Latest News

USPH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for USPH.

Price Targets

Consensus target: $102.00

USPH MoonshotScore

60/100

What does this score mean?

The MoonshotScore rates USPH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Christopher J. Reading

CEO

Christopher J. Reading serves as the Chief Executive Officer of U.S. Physical Therapy, Inc. His career spans several leadership roles within the healthcare and physical therapy sectors. Reading has been instrumental in driving the company's growth and expansion through strategic acquisitions and operational improvements. His expertise includes healthcare management, business development, and strategic planning. He is actively involved in industry associations and community initiatives, demonstrating a commitment to advancing the field of physical therapy.

Track Record: Under Christopher J. Reading's leadership, U.S. Physical Therapy, Inc. has expanded its clinic network to 591 locations across 39 states. He has overseen the successful integration of numerous acquisitions, contributing to the company's revenue growth and market share. Reading has also focused on enhancing the company's industrial injury prevention services, diversifying its revenue streams. His strategic decisions have positioned USPH as a leading provider of outpatient physical therapy services.

Common Questions About USPH (Healthcare)

What does U.S. Physical Therapy, Inc. do?

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics and provides industrial injury prevention services. The company's clinics offer a range of services, including pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The industrial injury prevention services segment provides onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments to Fortune 500 companies and other clients. USPH operates 591 clinics in 39 states.

What do analysts say about USPH stock?

Analyst coverage of U.S. Physical Therapy, Inc. is limited, but generally reflects a positive outlook based on the company's growth prospects and established market position. Key valuation metrics, such as the P/E ratio of 815.5, suggest a premium valuation, indicating investor expectations of future growth. Analysts often highlight the company's strategic acquisitions and decentralized operating model as key drivers of its success. However, they also caution about risks such as reimbursement rate pressures and competition. Analyst consensus typically reflects a hold or buy rating, with price targets based on projected earnings growth and market conditions. Investors should conduct their own due diligence and consider their individual risk tolerance before making any investment decisions.

What are the main risks for USPH?

U.S. Physical Therapy, Inc. faces several risks, including competition from other physical therapy providers, changes in reimbursement policies and rates, economic downturns affecting patient demand, rising operating costs, and regulatory changes in the healthcare industry. The fragmented nature of the physical therapy market creates intense competition, potentially impacting patient volume and pricing. Changes in reimbursement policies and rates from insurance providers can significantly affect revenue. An economic downturn could reduce patient demand for elective physical therapy services. Rising operating costs, including labor and rent, can erode profitability. Regulatory changes in the healthcare industry may require costly compliance measures. Investors should carefully consider these risks before investing in USPH.

What are the key factors to evaluate for USPH?

U.S. Physical Therapy, Inc. (USPH) holds an AI score of 60/100 (moderate). P/E: 815.5x vs the S&P 500's ~20-25x. Analysts target $102.00 (+40%). Not financial advice.

How frequently does USPH data refresh on this page?

USPH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven USPH's recent stock price performance?

U.S. Physical Therapy, Inc. (USPH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of 591 clinics in 39 states. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider USPH overvalued or undervalued right now?

U.S. Physical Therapy, Inc. (USPH) trades at 815.5x earnings. Analysts target $102.00 (+40%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying USPH?

Before investing in U.S. Physical Therapy, Inc. (USPH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available financial data and company reports as of 2021-12-31.
  • Market projections are based on third-party research and may not be indicative of actual results.
Data Sources

Popular Stocks